tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

VXRT Stock Latest News

Vaxart Provides Business Update and Reports First Quarter 2023 Financial Results  
Press ReleasesVaxart Provides Business Update and Reports First Quarter 2023 Financial Results  
28d ago
VXRT
Vaxart to host conference call
The FlyVaxart to host conference call
2M ago
VXRT
Vaxart to host conference call
The FlyVaxart to host conference call
2M ago
VXRT
Vaxart to Host Webcast with Key Opinion Leaders to Discuss the Health Impact and Disease Burden for Norovirus
Press ReleasesVaxart to Host Webcast with Key Opinion Leaders to Discuss the Health Impact and Disease Burden for Norovirus
3M ago
VXRT
Vaxart to host KOL webcast on health, economic impact for norovirus
The FlyVaxart to host KOL webcast on health, economic impact for norovirus
3M ago
VXRT
Vaxart Provides Business Update and Full Year 2022 Financial Results
Press ReleasesVaxart Provides Business Update and Full Year 2022 Financial Results
3M ago
VXRT
Vaxart to Host Full Year 2022 Business Update and Financial Results Conference Call on March 15
Press ReleasesVaxart to Host Full Year 2022 Business Update and Financial Results Conference Call on March 15
3M ago
VXRT
Vaxart options imply 40.1% move in share price post-earnings
The FlyVaxart options imply 40.1% move in share price post-earnings
3M ago
VXRT
Vaxart options imply 39.1% move in share price post-earnings
The FlyVaxart options imply 39.1% move in share price post-earnings
3M ago
VXRT
Vaxart doses first subject in Phase 2 trial of bivalent norovirus candidate
The FlyVaxart doses first subject in Phase 2 trial of bivalent norovirus candidate
4M ago
VXRT
Vaxart names Phillip Lee as Chief Financial Officer
The FlyVaxart names Phillip Lee as Chief Financial Officer
5M ago
VXRT
Vaxart price target lowered to $1.50 from $6 at B. Riley
The FlyVaxart price target lowered to $1.50 from $6 at B. Riley
5M ago
VXRT
Vaxart announces collaborative funding for study on Novovirus vaccine candidate
The FlyVaxart announces collaborative funding for study on Novovirus vaccine candidate
6M ago
VXRT
Vaxart to Present at World Vaccine & Immunotherapy Congress West Coast 2022 on November 29
Press ReleasesVaxart to Present at World Vaccine & Immunotherapy Congress West Coast 2022 on November 29
6M ago
VXRT
Vaxart Provides Business Update and Reports Third Quarter 2022 Financial Results
Press ReleasesVaxart Provides Business Update and Reports Third Quarter 2022 Financial Results
7M ago
VXRT
Vaxart to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 8
Press ReleasesVaxart to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 8
7M ago
VXRT
Vaxart to Present at World Vaccine Congress Europe 2022 on October 13
Press ReleasesVaxart to Present at World Vaccine Congress Europe 2022 on October 13
8M ago
VXRT
Vaxart Announces Positive Top-line Phase II Clinical Study Data Demonstrating Safety and Immunogenicity of Its Wuhan S-Only COVID-19 Pill Vaccine Candidate
Press ReleasesVaxart Announces Positive Top-line Phase II Clinical Study Data Demonstrating Safety and Immunogenicity of Its Wuhan S-Only COVID-19 Pill Vaccine Candidate
9M ago
VXRT
Vaxart to Host Conference Call on September 1 at 8:30 AM ET to Discuss Top-line Results from Its Phase II COVID-19 Trial
Press ReleasesVaxart to Host Conference Call on September 1 at 8:30 AM ET to Discuss Top-line Results from Its Phase II COVID-19 Trial
9M ago
VXRT
Vaxart Announces Highly Regarded Biotech Executive Elaine J. Heron, Ph.D. Joins Board of Directors
Press ReleasesVaxart Announces Highly Regarded Biotech Executive Elaine J. Heron, Ph.D. Joins Board of Directors
9M ago
VXRT
Vaxart Announces Highly Regarded Biotech Executive Elaine J. Heron, Ph.D. Joins Board of Directors
Press ReleasesVaxart Announces Highly Regarded Biotech Executive Elaine J. Heron, Ph.D. Joins Board of Directors
9M ago
VXRT
Vaxart Provides Business Update and Reports Second Quarter 2022 Financial Results
Press ReleasesVaxart Provides Business Update and Reports Second Quarter 2022 Financial Results
10M ago
VXRT